<?xml version="1.0" encoding="UTF-8"?>
<p>“Administrative approval for the study was issued by the Regional Delegation of Public Health of the Northwest region and from the Chantal BIYA International Reference Centre for research on HIV/AIDS prevention and management (Ref. N° 2112/016L/CIRCB/DIR/CL); ethical approval for the research was obtained from the Cameroon National Ethics Committee for Research on Human Health (Ref. N° 2017/03/893/L/CNERSH/SP), and the Institutional Review Board (IRB) of Faculty of Medicine and Biomedical Sciences of the University of Yaoundé I (Ref. N° 211/UYI/FMSB/VDRC/CSD). Following study information to each respondent, a written informed consent was obtained after having been clearly intimated with the objectives, methodology, advantages and potential risks involved in the study. Participation was voluntary throughout the study and any participant was free to decline participating in the study at any time without any prejudice. Participants were treated equally irrespective of their social status and other related status. Confidentiality and privacy were ensured by using no identification information. Genotypic results were freely returned to participants for possible clinical benefits in their therapeutic management.” </p>
